Research and Markets: Stem Cell & Regenerative Medicine

<0> Research and Markets: Stem Cell & Regenerative Medicine </0>

<0> Research and MarketsLaura Wood, Senior ManagerU.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Sector: , </0>

() has announced the addition of the "" book to their offering.

The potential use of stem cells in transplantation for the purpose of tissue regeneration is an exciting area of research currently undergoing rapid development. Implantation of human embryonic or autologous, ex vivo-expanded adult stem cells, particularly in older individuals, could circumvent the limited availability of organs/tissues as well as prevent complications related to immune rejection and disease transmission. Musculoskeletal tissue degeneration is closely associated with aging. Strategies employing autologous adult MSCs from older individuals for transplantation in order to regenerate their own ailing organ or tissues require that we vigorously define MSCs capacity to maintain growth potential and differentiation potential into the desirable cell lineages. We are currently restricted by the limited knowledge about physical parameters, such as biomechanical forces, that influence MSC growth and differentiation capacities. This is particularly important for MSCs isolated from older individuals, for whom little information is available.

This aims to serve as an impetus in generating more interest among stem cell researchers and biotechnologists to improve and develop the cell-based therapies of damaged tissue using stem cells.





1 Justice and Vulnerability in Human Embryonic Stem Cell Research

2 Stem Cells and their Contribution to Tissue Repair

3 The Role of Microenvironments Stromal Cells in Regenerative Medicine

4 The Role of Mechanical Forces on Stem Cell Growth and Differentiation

5 Functional Cartilage Tissue Engineering with Adult Stem Cells: Current Status and Future Directions

6 Therapeutic Angiogenesis for Coronary Artery Disease: Clinical Trials of Proteins, Plasmids, Adenovirus and Stem Cells

7 Use of Progenitor Cells in Pain Management

8 Neural Stem Cells: New Hope for Successful Therapy

9 Diabetes and Stem Cells

10 Stem Cells in Dentistry

11 Corneal Progenitor Cells and Regenerative Potential


Suggested Articles

Sumitovant CEO Myrtle Potter discusses the $3 billion Roivant-Sumitomo deal, her role at Sumitovant and what's up in 2020.

Antibiotics player Summit Therapeutics is gearing up for a new clinical trial of its lead asset, an antibiotic for Clostridium difficile infection.

In this week's EuroBiotech Report, Roche's risdiplam clears another phase 3 SMA trial, Merck KGaA spinout raises cash and Korean VCs back PDC*line.